HUNTINGDON VALLEY, Pa. & SAN ANTONIO--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ-CM:IMMC) announced today that three independent studies featuring Immunicon’s CellTracks® technology and the CellSearch™ Circulating Tumor Cell Kit will be presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS). The meeting is the premier educational and scientific event in breast oncology and will take place December 13-16 at the Henry B. Gonzalez Convention Center, San Antonio, Texas. Research conducted at MD Anderson, the University of Michigan, and the Lombardi Cancer Center at Georgetown University and others will be discussed at a Thursday December 13th afternoon session dedicated solely to circulating tumor cell research in breast cancer.
